Spot on @ddwn - people that know a lot more about this than us know it works.
IMO, our biggest challenge comes from the threat that stem cells pose to big Pharma's existing revenue streams.
I'm happy we have Novartis on board.
It will get approved either when Big Pharma says so or when irrefutable evidence is put forward.
Cell Therapy News/Articles, page-9158
-
- There are more pages in this discussion • 8,668 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94863 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 5000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |